Exploring the clinical value of innovations in lipid management

Lipid Innovations Master Class

News - Oct. 1, 2012

Exploring the clinical value of innovations in lipid management

September 21-22, 2012,

This Master Class program is an initiative of the Physicians Academy for Cardiovascular Education (PACE) foundation with a particular focus on issues and opportunities in lipid management in high risk patients.

Educational objectives of this Master Class are:

  • To explore the mechanisms underlying the complex interplay between the clinical benefit of (combined) lipid modulation and baseline serum lipid levels.
  • To review new data on effective lipid lowering and its relevance to treatment strategies and outcomes
  • To review the clinical significance of additional lipid lowering pathways in the management of atherosclerosis
  • To evaluate the effects of new HDL-C raising therapies on the risk of cardiovascular events in CV risk patients
  • To understand the medical need for aggressive lipid management in patients at high CV risk, such as DM and metabolic syndrome
  • To develop a consensus on practical guidelines for day-to-day lipid management of patients with atherosclerosis and CV risk

Preliminary Agenda

Meeting Chairmen

  • John J P Kastelein,MD, Professor of Medicine, Academic Medical Centre, Amsterdam, The Netherlands
  • John Betteridge, MD,  Emeritus Professor of Endocrinology & Metabolism, University College London, United Kingdom
Friday, September 21
18:00 - 20:45

New concepts and guidelines in the management of LDL-c and CV Risk: Need for early intervention
Prof. Ulf Landmesser, MD
University Hospital Zurich,

Latest insights from clinical trials: The unassailable case for LDL-c lowering
Prof. Kausik Ray, MD
George’s Hospital NHS Trust
London, United Kingdom

Residual risk and HDL-cholesterol: What are the current perspectives in management?
Prof. Erik Stroes, MD
Academic Medical Centre
Amsterdam, The Netherlands

Saturday, September 22
08:30 - 14:00

Lipid management in clinical practice: Need for improvement?
Prof Richard Hobbs, MD
University of Oxford, United Kingdom

The importance of lipid lowering through liver and intestine: An overview of all relevant data for atherosclerosis
Prof. Alberto Corsini, PhD
University of Milan,  Milan, Italy

Lipid management in the diabetic patient What are the therapeutic options?
Prof. John Betteridge, MD
University College London, United Kingdom

Protecting the heart and the kidney: Implications from the SHARP trial
Christina Reith, MD
University of Oxford, United Kingdom

Novel therapies for the prevention of atherosclerotic vascular disease
Prof John Kastelein, MD
Academic Medical Centre, Amsterdam, The Netherlands

Workshops sessions- Meet the expert: Defining take home messages

CME accreditation

The Scientific programme is developed under the auspices of the Physicians’ Academy for Cardiovascular Education
(PACE) Foundation and supervised by the University College London. This PACE Lipid Master Class is accredited by
the European Board for Accreditation in Cardiology (EBAC) for 6 CME credit hours (Day #1: 2 CME credits - Day #2: 4
CME credits). Each participant should claim only those hours of credit that have actually been spent in the educational
activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical
Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

Who should attend

Participants to this Master Class are medical specialists; cardiologists, internists, endocrinologists with a particular interest in lipid management in patients in patients with increased risk. The attendance is limited to ensure lively interaction and discussion.

Meeting venue

Hilton Hotel, Budapest, Hungary



This conference is supported through an unrestricted educational grant provided by MSD

Facebook Comments


We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free